Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EQUIFAX INCEFX · Entity 3235 | President - USIS | February 25, 2022 | March 01, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EQUIFAX INC
Report date February 25, 2022 · Filed March 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,200 |
Last balance in matching sequence
After 2022-02-25 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
7 source rowsRow 1 · 2022-02-25 · Exercise / conversion · Acquired 8,872 · Balance 30,072 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 2 · 2022-02-25 · Exercise / conversion · Acquired 7,339 · Balance 37,411 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 3 · 2022-02-25 · Exercise / conversion · Acquired 3,011 · Balance 40,422 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 4 · 2022-02-25 · Sale · Disposed 2,332 · Balance 38,090 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F3: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $213.60 to $214.575, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 5 · 2022-02-25 · Sale · Disposed 3,398 · Balance 34,692 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F4: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $214.61 to $215.60, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 6 · 2022-02-25 · Sale · Disposed 3,458 · Balance 31,234 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F5: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $216.66 to $217.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Row 7 · 2022-02-25 · Sale · Disposed 10,034 · Balance 21,200 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F6: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $215.65 to $216.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. |
| Stock Option/Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $110.76 · Expires 2029-02-22 | Direct | 0 |
Reported balance
After 2022-02-25 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-02-25 · Exercise / conversion · Disposed 3,011 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F7: The option vests in three equal annual increments beginning 2/22/2020. |
| Stock Option/Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $127.37 · Expires 2025-02-22 | Direct | 0 |
Reported balance
After 2022-02-25 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-02-25 · Exercise / conversion · Disposed 7,339 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. |
| Stock Option/Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $138.45 · Expires 2025-02-22 | Direct | 0 |
Reported balance
After 2022-02-25 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-02-25 · Exercise / conversion · Disposed 8,872 · Balance 0 F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $213.60 to $214.575, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F4: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $214.61 to $215.60, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $216.66 to $217.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $215.65 to $216.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F7: The option vests in three equal annual increments beginning 2/22/2020.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Paya Holdings Inc.
Report date February 22, 2023 · Filed February 24, 2023
Section 16 reporting ended · disclosed 2023-02-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-02-22 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2023-02-22 · Other · Disposed 4,600 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of January 8, 2023, by and among Paya Holdings Inc., Nuvei Corporation, a corporation incorporated pursuant to the laws of Canada and Pinnacle Merger Sub, Inc. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-02-22 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2023-02-22 · Disposition to issuer · Disposed 40,472 · Balance 0 F2: Each of the Issuer's RSU outstanding and vested as of immediately prior to the Effective Time, was cancelled and converted into the right to receive a lump sum cash payment. Any RSUs that were outstanding and unvested as of immediately prior to the Effective Time were converted into a restricted stock unit award. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of January 8, 2023, by and among Paya Holdings Inc., Nuvei Corporation, a corporation incorporated pursuant to the laws of Canada and Pinnacle Merger Sub, Inc.
F2: Each of the Issuer's RSU outstanding and vested as of immediately prior to the Effective Time, was cancelled and converted into the right to receive a lump sum cash payment. Any RSUs that were outstanding and unvested as of immediately prior to the Effective Time were converted into a restricted stock unit award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2023 Filed Feb 24, 2023 19:33 UTC | Paya Holdings Inc. PAYA · Entity 116479 | Disposition to issuerCommon Stock | 40,472 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-23-014489 · ownership.xml · nonDerivative · entry 2 Singh Sid · CIK 0001768422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Each of the Issuer's RSU outstanding and vested as of immediately prior to the Effective Time, was cancelled and converted into the right to receive a lump sum cash payment. Any RSUs that were outstanding and unvested as of immediately prior to the Effective Time were converted into a restricted stock unit award. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 19:33 UTC | Paya Holdings Inc. PAYA · Entity 116479 | OtherCommon Stock | 4,600 | $9.75 | $44,850.00 |
DisclosureSEC source: 0001213900-23-014489 · ownership.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · acquired: Pursuant to the Agreement and Plan of Merger, dated as of January 8, 2023, by and among Paya Holdings Inc., Nuvei Corporation, a corporation incorporated pursuant to the laws of Canada and Pinnacle Merger Sub, Inc. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 18:03 UTC | Paya Holdings Inc. PAYA · Entity 116479 | GrantCommon Stock | 22,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-004823 · primarydocument.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,072 F1 · shares: Consists of restricted stock units which vest on June 1, 2023. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 8,872 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · derivative · entry 10 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,872 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 7,339 | $0.00 Strike: $127.37 | $0.00 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · derivative · entry 9 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,339 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 3,011 | $0.00 Strike: $110.76 | $0.00 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · derivative · entry 8 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,011 shares Expires 2029-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F7 · derivative.exercise_date: The option vests in three equal annual increments beginning 2/22/2020. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 10,034 | $216.20 | $2,169,392.94 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · nonDerivative · entry 7 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $215.65 to $216.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 3,458 | $217.11 | $750,766.03 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · nonDerivative · entry 6 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,234 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $216.66 to $217.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 3,398 | $215.17 | $731,145.96 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · nonDerivative · entry 5 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,692 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $214.61 to $215.60, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,332 | $214.09 | $499,266.74 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · nonDerivative · entry 4 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,090 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $213.60 to $214.575, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 3,011 | $110.76 | $333,498.36 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · nonDerivative · entry 3 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 7,339 | $127.37 | $934,768.43 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · nonDerivative · entry 2 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 8,872 | $138.45 | $1,228,328.40 |
DisclosureSEC source: 0001225208-22-003709 · doc4.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 8,388 | $212.24 | $1,780,269.12 |
DisclosureSEC source: 0001225208-22-003260 · doc4.xml · nonDerivative · entry 2 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,200 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 16,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003260 · doc4.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,588 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:53 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 12,434 | $0.00 Strike: $225.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002207 · doc4.xml · derivative · entry 2 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,434 Underlying: Common Stock · 12,434 shares Expires 2032-02-11 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/11/2023. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:53 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 3,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002207 · doc4.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,313 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 08:46 UTC | Paya Holdings Inc. PAYA · Entity 116479 | GrantCommon Stock | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-050976 · ownership.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 F1 · shares: Consists of restricted stock units which vest in five equal annual installments beginning on September 30, 2022. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 6,021 | $0.00 Strike: $110.76 | $0.00 |
DisclosureSEC source: 0001225208-21-011700 · doc4.xml · derivative · entry 5 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,011 Underlying: Common Stock · 6,021 shares Expires 2029-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021. F6 · derivative.exercise_date: The option vests in three equal annual increments beginning 2/22/2020. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 4,224 | $257.19 | $1,086,353.66 |
DisclosureSEC source: 0001225208-21-011700 · doc4.xml · nonDerivative · entry 4 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,183 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $256.76 to $257.73, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 3,209 | $256.19 | $822,100.87 |
DisclosureSEC source: 0001225208-21-011700 · doc4.xml · nonDerivative · entry 3 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,407 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $255.715 to $256.665, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 195 | $258.04 | $50,317.41 |
DisclosureSEC source: 0001225208-21-011700 · doc4.xml · nonDerivative · entry 2 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,616 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $257.815 to $258.50, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 20:13 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 6,021 | $110.76 | $666,885.96 |
DisclosureSEC source: 0001225208-21-011700 · doc4.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 5/24/2021. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:10 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,822 | $237.17 | $669,299.95 |
DisclosureSEC source: 0001225208-21-007668 · doc4.xml · nonDerivative · entry 5 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,767 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/25/2021. F7 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $236.72 to $237.68, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:10 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 2,681 | $238.13 | $638,418.49 |
DisclosureSEC source: 0001225208-21-007668 · doc4.xml · nonDerivative · entry 4 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,589 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/25/2021. F6 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $237.77 to $238.75, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:10 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 1,500 | $236.07 | $354,098.40 |
DisclosureSEC source: 0001225208-21-007668 · doc4.xml · nonDerivative · entry 3 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,270 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/25/2021. F5 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $235.71 to $236.66, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:10 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 1,324 | $240.25 | $318,096.16 |
DisclosureSEC source: 0001225208-21-007668 · doc4.xml · nonDerivative · entry 2 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,770 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/25/2021. F4 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $239.82 to $240.71, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:10 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 859 | $239.32 | $205,572.79 |
DisclosureSEC source: 0001225208-21-007668 · doc4.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,094 F1 · kind: The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 2/25/2021. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $238.80 to $239.75, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. F3 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 21:30 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 6,241 | $169.93 | $1,060,533.13 |
DisclosureSEC source: 0001225208-21-003465 · doc4.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,953 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:23 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 7,338 | $0.00 Strike: $177.19 | $0.00 |
DisclosureSEC source: 0001225208-21-002799 · doc4.xml · derivative · entry 2 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,338 Underlying: Common Stock · 7,338 shares Expires 2031-02-12 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/12/2022. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:23 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002799 · doc4.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,194 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/12/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2020 Filed Feb 25, 2020 21:55 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 6,180 | $159.53 | $985,895.40 |
DisclosureSEC source: 0001225208-20-003452 · doc4.xml · nonDerivative · entry 2 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,233 F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:55 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 6,019 | $0.00 Strike: $175.48 | $0.00 |
DisclosureSEC source: 0001225208-20-003452 · doc4.xml · derivative · entry 4 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,019 Underlying: Common Stock · 6,019 shares Expires 2026-02-21 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:55 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 7,594 | $0.00 Strike: $191.44 | $0.00 |
DisclosureSEC source: 0001225208-20-003452 · doc4.xml · derivative · entry 3 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,594 Underlying: Common Stock · 7,594 shares Expires 2026-02-21 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:55 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003452 · doc4.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,413 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/21/2023. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 7,339 | $0.00 Strike: $127.37 | $0.00 |
DisclosureSEC source: 0001225208-19-003788 · doc4.xml · derivative · entry 6 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,339 Underlying: Common Stock · 7,339 shares Expires 2025-02-22 F4 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 8,872 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001225208-19-003788 · doc4.xml · derivative · entry 5 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,872 Underlying: Common Stock · 8,872 shares Expires 2025-02-22 F4 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 10,697 | $0.00 Strike: $149.53 | $0.00 |
DisclosureSEC source: 0001225208-19-003788 · doc4.xml · derivative · entry 4 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,697 Underlying: Common Stock · 10,697 shares Expires 2025-02-22 F4 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 9,032 | $0.00 Strike: $110.76 | $0.00 |
DisclosureSEC source: 0001225208-19-003788 · doc4.xml · derivative · entry 3 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,032 Underlying: Common Stock · 9,032 shares Expires 2029-02-22 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/22/2020. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,257 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-003788 · doc4.xml · nonDerivative · entry 2 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,343 F2 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/22/2022. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 27,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-003788 · doc4.xml · nonDerivative · entry 1 Singh Sid · CIK 0001768422 · President - USIS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,086 F1 · security: New hire equity grant pursuant to the Company's long-term incentive plan. The award of retricted stock units vests 50% on 2/22/2020 and 50% on 2/22/2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.